Evaluation of Eflornithine on Facial and Forearm Skin

• Status: Completed
• Trial end date: 2005-10-31
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate whether regular use of eflornithine 11.5% cream in treating women with facial hair will induce skin damage (atrophy) on the face and/or forearms

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan; Shire
• Treatments: Eflornithine

Criteria

Inclusion Criteria:

• Female subjects with clinical diagnosis of facial hirsutism/excessive facial hair

• Women of childbearing potential must agree to use an effective form of birth control for the duration of the study

• Skin type I-IV

• Customary frequency of removal of facial hair two or more times per week

Exclusion Criteria:

• Pregnant or lactating women

• Severe inflammatory acne or presence of significant scarring on the face

• History of skin malignancy

• Connective tissue disorders